Molecular Modeling

Umfassend und präzise, besonders für Anfänger gut verständlich: Dieser Band erklärt die Grundlagen der Molekülmodellierung kompetent und nachvollziehbar. Ausführlichen Informationen zur Modellierung von kleinen Molekülen und Proteinen folgen durchgearbeitete Beispiele, die dem Leser den Weg zum ersten eigenen Experiment ebnen. Neu in dieser dritten Auflage ist ein Kapitel zur Chemogenomik, das (gemeinsam mit dem überarbeiteten und erweiterten Beispiel zur Behandlung komplizierterer Biomoleküle) den gegenwärtigen Trend zur "chemischen Biologie" widerspiegelt. Die Autoren, erfahrene Dozenten in diesem Themenbereich, garantieren die Praxistauglichkeit des Bandes als Begleiter einschlägiger Vorlesungen. Für Fachleute interessant: Als einziges gegenwärtig erhältliches Werk enthält das Buch einen systematischen Vergleich der Möglichkeiten und Grenzen moderner MM-Verfahren und entsprechender Software-Pakete.

Auteur
Hans-Dieter Höltje is director of the Institute of Pharmaceutical Chemistry at the Heinrich-Heine-Universität Düsseldorf (Germany) where he also holds the chair of Medicinal Chemistry. His main interest is the molecular mechanism of drug action. Wolfgang Sippl is Professor of Pharmaceutical Chemistry at the Martin-Luther-University of Halle-Wittenberg (Germany). He is interested in 3D QSAR, molecular docking and molecular dynamics, and their applications in drug design and pharmacokinetics. Didier Rognan leads the Drug Bioinformatics Group at the Laboratory for Molecular Pharmacochemistry in Illkirch (France). He is mainly interested in all aspects (method development, applications) of protein-based drug design and virtual screening. Gerd Folkers is Professor of Pharmaceutical Chemistry at the ETH Zürich (Switzerland). The focus of his research is the molecular interation between drugs and their binding sites.

Texte du rabat
Creating a computer model of a molecule with known or unknown structure that can then be studied by computational means is a key skill for biochemists, molecular biologists and aspiring drug developers. Increasingly sophisticated modeling software requires at least a basic understanding of the method in order to avoid misinterpretation of the data generated. Ideal for beginners, this book explains the basics of modeling in a competent yet easily understandable way, with completely worked-out examples to guide readers to their first modeling experiments. This third edition features a new chapter on chemogenomics, reflecting the trend towards 'chemical biology', while the example of protein modeling is completely rewritten for a better 'feel' of modeling complex biomolecules. The authors are experienced university lecturers who regularly hold courses on molecular modeling, making this a tried-and-tested text for teachers. It is equally valuable for experts, since it is the only book to evaluate the strengths and limitations of the molecular modeling techniques and software currently available.

Contenu
Introduction Small Molecules - Generation of 3D-Coordinates - Computational Tools for Geometry Optimization - Conformational Analysis - Determination of Molecular Interaction Potentials - Pharmacophore Identification - 3D QSAR Methods A Case Study for Small Molecule Modeling: Dopamine D3 Receptor Antagonists - Building a Pharmacophore Model - 3D QSAR Analysis Introduction to Comparative Protein Modeling - Where and How to get Information on Proteins - Terminology and Principles of Protein Structure - Comparative Protein Modeling - Optimization Procedures - Model Refinement - Molecular Dynamics - Validation of Protein Models - Properties of Proteins Virtual Screening and Docking - Preparation of the Partners - Docking Algorithms - Scoring Functions - Postfiltering Virtual Screening Results - Comparison of Different Docking and Scoring Methods - Examples of successful Virtual Screening Studies Scope and Limits of Molecular Docking - Docking in the Polar Active Site that Contains Water - Including Cofactor in Docking? (NEW) - Impact of Tautomerism on Docking (NEW) Chemogenomic Approaches to Rational Drug Design (NEW) - Description of Ligand and Target Spaces - Ligand-based Chemogenomic Approaches - Targed-based Chemogenomic Approaches - Target-Ligand Based Chemogenomic Approaches A Case Study for Protein Modeling: the Nuclear Hormone Receptor CAR as an Example for Comparative Modeling and the Analysis of Protein-Ligand Complexes (NEW) - The Biochemical and Pharmacological Description of the Problem - Comparative Modeling of the Human Nuclear Hormone Receptor CAR - Analysis of the Models that Emerged from MD Simulations - Analysis of CAR Mutants - Modeling of CAR-Ligand Complexes - The CAR X-Ray Structure Comes into Play - Virtual Screening for Novel CAR Activators